CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Revenue	$ 461.4	$ 431.7
Cost of revenue	246.7	232.3
Gross profit	214.7	199.4
Operating expenses:
Selling, general and administrative	120.1	110.3
Research and development	46.4	43.2
Other charges, net	6.3	7.8
Total operating expenses	172.8	161.3
Operating income	41.9	38.1
Interest and other income (expense), net	(3.5)	(2.3)
Income before income taxes and noncontrolling interest in consolidated subsidiaries	38.4	35.8
Income tax provision	7.7	8.4
Consolidated net income	30.7	27.4
Net (loss) income attributable to noncontrolling interests in consolidated subsidiaries	(0.1)	0.4
Net income attributable to Bruker Corporation	$ 30.8	$ 27.0
Net income per common share attributable to Bruker Corporation shareholders:
Basic (in dollars per share)	$ 0.20	$ 0.17
Diluted (in dollars per share)	$ 0.20	$ 0.17
Weighted average common shares outstanding:
Basic (in shares)	156.7	155.9
Diluted (in shares)	157.9	157.0
Comprehensive income	$ 17.0	$ 51.8
Less: Comprehensive income attributable to noncontrolling interests	(0.1)	0.6
Comprehensive income attributable to Bruker Corporation	$ 17.1	$ 51.2
Dividend declared per common share (in dollars per share)	$ 0.04	$ 0.04
Product
Revenue	$ 383.0	$ 352.2
Cost of revenue	197.5	185.6
Service
Revenue	77.4	77.7
Cost of revenue	49.1	46.5
Other
Revenue	1.0	1.8
Cost of revenue	$ 0.1	$ 0.2